av/sernova--big.svg

NASDAQ:SVA

Sinovac Biotech Ltd.

  • Stock

USD

Last Close

6.47

28/08 20:00

Market Cap

464.94M

Beta: -

PE Ratio

5.65

PFCF: −0.40

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
12.46M
-
16.62M
33.31%
18.76M
12.90%
16.39M
12.61%
16.86M
2.85%
22.35M
32.59%
26.47M
18.40%
66.83M
152.49%
240.66M
260.11%
278.12M
15.56%
average payables
26.73M
-
25.64M
4.09%
12.48M
51.34%
13.34M
6.91%
15.87M
18.99%
6.16M
61.22%
32.21M
423.31%
135.16M
319.62%
135.01M
0.11%
482.26M
257.20%
average receivables
27.69M
-
36.35M
31.27%
39.89M
9.73%
44.43M
11.38%
58.02M
30.59%
71.83M
23.81%
95.60M
33.08%
183.61M
92.06%
602.94M
228.38%
780.95M
29.52%
book value per share
2.33
-
2.27
2.32%
2.19
3.69%
2.03
7.14%
2.65
30.37%
3.92
47.74%
3.10
20.85%
7.55
143.56%
93.92
1,144.32%
89.66
4.54%
capex per share
-0.09
-
-0.20
111.13%
-0.09
52.38%
-0.22
136.62%
-0.21
6.17%
-0.09
58.49%
-0.11
29.18%
-1.29
1,052.25%
-7.25
461.67%
-4.05
44.08%
capex to depreciation
-0.76
-
-1.31
72.74%
-0.81
37.71%
-2.38
191.94%
-2.44
2.73%
-1.09
55.23%
-2.21
101.89%
-31.62
1,333.14%
-8.29
73.78%
-2.58
68.93%
capex to operating cash flow
-0.91
-
1.27
239.49%
-1.99
256.50%
0.82
141.26%
-0.19
123.63%
-0.71
263.88%
-0.27
61.51%
-0.27
2.09%
-0.05
82.39%
0.52
1,215.97%
capex to revenue
-0.07
-
-0.17
144.32%
-0.08
54.92%
-0.17
121.20%
-0.07
60.70%
-0.02
64.24%
-0.04
76.72%
-0.25
478.76%
-0.04
85.14%
-0.27
627.16%
cash per share
1.94
-
1.64
15.24%
1.13
31.03%
1.10
3.28%
2.01
82.99%
2.74
36.37%
2.14
21.79%
11.89
455.90%
135.08
1,035.75%
113.69
15.83%
days of inventory on hand
247.06
-
416.76
68.69%
370.15
11.18%
229.86
37.90%
353.78
53.91%
370.43
4.71%
313.03
15.50%
574.90
83.66%
127.83
77.76%
96.37
24.61%
days payables outstanding
481.06
-
514.25
6.90%
33.97
93.39%
406.84
1,097.50%
122.27
69.95%
81.64
33.23%
662.01
710.87%
1.15K
73.52%
19.94
98.26%
483.10
2,322.18%
days sales outstanding
160.78
-
235.75
46.63%
211.27
10.38%
249.41
18.05%
138.60
44.43%
123.12
11.17%
168.72
37.04%
181.20
7.40%
17.94
90.10%
149.03
730.61%
debt to assets
0.20
-
0.22
8.02%
0.12
43.25%
0.20
65.30%
0.13
34.22%
0.04
71.90%
0.04
19.09%
0.07
60.05%
0.01
87.94%
0.01
38.85%
debt to equity
0.38
-
0.41
8.84%
0.20
50.42%
0.37
83.29%
0.27
28.68%
0.05
79.29%
0.07
25.56%
0.18
165.01%
0.02
91.50%
0.01
46.12%
dividend yield
2.92
-
0.41
86.00%
earnings yield
0.02
-
-0.00
113.29%
-0.00
14.10%
-0.00
98.84%
0.06
145,923.03%
0.05
14.05%
0.11
119.09%
0.29
172.41%
22.50
7,675.51%
0.14
99.39%
enterprise value
279.56M
-
252.97M
9.51%
283.28M
11.98%
316.60M
11.76%
383.07M
21.00%
304.95M
20.39%
481.41M
57.86%
-264.76M
155.00%
-10.82B
3,987.31%
-3.56B
67.11%
enterprise value over ebitda
15.44
-
19.42
25.80%
24.66
26.96%
39.88
61.71%
7.43
81.36%
5.77
22.39%
6.29
8.97%
-1.19
118.95%
-0.61
48.54%
-18.90
2,983.78%
ev to operating cash flow
49.27
-
-29.25
159.38%
106.46
463.90%
-20.52
119.27%
6.24
130.43%
38.39
514.92%
12.32
67.91%
-0.55
104.48%
-0.70
27.61%
4.62
755.23%
ev to sales
3.85
-
4.01
4.00%
4.20
4.82%
4.34
3.31%
2.20
49.39%
1.33
39.56%
1.96
47.34%
-0.52
126.50%
-0.56
7.72%
-2.38
326.95%
free cash flow per share
0.01
-
-0.35
4,018.87%
-0.05
86.73%
-0.49
953.77%
0.87
275.60%
0.04
95.85%
0.30
732.90%
3.56
1,085.98%
147.34
4,043.65%
-11.80
108.01%
free cash flow yield
0.00
-
-0.07
4,685.75%
-0.01
87.86%
-0.08
921.62%
0.11
229.18%
0.01
95.20%
0.05
793.40%
0.55
1,085.98%
22.77
4,043.65%
-1.82
108.01%
graham net net
0.75
-
0.62
16.65%
0.68
8.85%
0.44
34.84%
0.91
105.49%
2.62
188.96%
2.13
18.83%
6.45
202.87%
115.25
1,686.22%
105.11
8.80%
graham number
2.65
-
0.88
66.69%
0.97
9.63%
0.10
89.46%
5.19
4,983.54%
5.44
4.82%
6.92
27.15%
17.83
157.58%
554.68
3,010.51%
42.27
92.38%
income quality
0.55
-
25.74
4,603.44%
5.17
79.92%
6.44
24.70%
1.67
74.06%
0.22
86.84%
0.60
172.39%
2.59
332.00%
1.06
58.98%
-8.75
923.64%
intangibles to total assets
0.00
-
0.05
1,306.03%
0.05
4.59%
0.04
12.76%
0.03
26.68%
0.02
25.57%
0.02
21.58%
0.01
70.97%
0.00
51.87%
0.01
128.95%
interest coverage
2.89
-
0.14
95.04%
1.94
1,253.77%
0.71
63.64%
28.95
4,005.70%
42.35
46.31%
105.48
149.06%
148.41
40.70%
6.19K
4,070.42%
25.09
99.59%
interest debt per share
0.93
-
0.99
6.63%
0.48
51.76%
0.79
64.41%
0.73
7.11%
0.23
68.29%
0.22
4.76%
1.39
532.07%
1.49
6.74%
0.76
48.70%
inventory turnover
1.48
-
0.88
40.72%
0.99
12.59%
1.59
61.03%
1.03
35.03%
0.99
4.49%
1.17
18.34%
0.63
45.55%
2.86
349.74%
3.79
32.64%
invested capital
0.38
-
0.41
8.84%
0.20
50.42%
0.37
83.29%
0.27
28.68%
0.05
79.29%
0.07
25.56%
0.18
165.01%
0.02
91.50%
0.01
46.12%
market cap
338.44M
-
291.21M
13.96%
322.12M
10.61%
336.00M
4.31%
457.41M
36.13%
449.21M
1.79%
613.85M
36.65%
639.87M
4.24%
642.55M
0.42%
643.78M
0.19%
net current asset value
60.27M
-
58.00M
3.76%
64.28M
10.83%
52.55M
18.25%
81.81M
55.68%
206.32M
152.20%
249.50M
20.93%
779.09M
212.26%
12.04B
1,445.77%
10.72B
10.95%
net debt to ebitda
-3.25
-
-2.94
9.69%
-3.38
15.11%
-2.44
27.70%
-1.44
40.98%
-2.73
89.16%
-1.73
36.62%
-4.07
135.32%
-0.65
84.04%
-22.32
3,337.39%
net income per share
0.13
-
-0.02
111.36%
-0.02
24.79%
-0.00
98.80%
0.45
198,320.46%
0.34
25.63%
0.69
104.26%
1.87
172.41%
145.59
7,675.51%
0.89
99.39%
operating cash flow per share
0.10
-
-0.16
251.36%
0.05
130.43%
-0.27
673.46%
1.08
496.99%
0.12
88.59%
0.41
235.61%
4.85
1,076.80%
154.59
3,089.70%
-7.75
105.01%
payables turnover
0.76
-
0.71
6.45%
10.74
1,413.64%
0.90
91.65%
2.99
232.75%
4.47
49.76%
0.55
87.67%
0.32
42.37%
18.30
5,659.48%
0.76
95.87%
receivables turnover
2.27
-
1.55
31.80%
1.73
11.59%
1.46
15.29%
2.63
79.95%
2.96
12.58%
2.16
27.03%
2.01
6.89%
20.34
909.89%
2.45
87.96%
research and ddevelopement to revenue
0.12
-
0.17
51.26%
0.14
19.50%
0.17
23.20%
0.12
32.24%
0.10
18.82%
0.10
3.32%
0.10
3.13%
0.01
91.62%
0.30
3,601.13%
return on tangible assets
0.03
-
-0.00
112.04%
-0.01
48.63%
-0.00
98.84%
0.09
138,735.35%
0.06
32.24%
0.15
143.57%
0.10
33.30%
0.87
784.05%
0.01
99.27%
revenue per share
1.31
-
1.13
13.59%
1.20
5.63%
1.28
6.97%
3.06
138.72%
3.55
16.06%
2.59
26.90%
5.16
99.09%
195.09
3,678.53%
15.00
92.31%
roe
0.06
-
-0.01
111.63%
-0.01
29.57%
-0.00
98.71%
0.17
152,142.52%
0.09
49.66%
0.22
158.07%
0.25
11.84%
1.55
524.88%
0.01
99.36%
roic
0.06
-
-0.00
101.30%
0.00
620.60%
-0.05
1,164.20%
0.19
526.30%
0.13
32.11%
0.20
49.88%
0.19
3.68%
1.51
693.98%
0.01
99.19%
sales general and administrative to revenue
0.58
-
0.35
-
0.03
91.17%
shareholders equity per share
2.33
-
2.27
2.32%
2.19
3.69%
2.03
7.14%
2.65
30.37%
3.92
47.74%
3.10
20.85%
7.55
143.56%
93.92
1,144.32%
89.66
4.54%
stock based compensation to revenue
0.00
-
0.00
17.39%
0.01
210.49%
0.03
133.92%
0.01
83.00%
0.02
233.84%
0.01
34.89%
0.02
63.72%
0.00
98.00%
tangible asset value
142.87M
-
130.97M
8.33%
129.17M
1.38%
120.97M
6.35%
168.11M
38.97%
283.62M
68.71%
344.23M
21.37%
1.11B
222.58%
13.83B
1,145.92%
12.63B
8.69%
tangible book value per share
2.58
-
2.35
8.95%
2.29
2.48%
2.12
7.39%
2.95
38.76%
4.38
48.66%
3.63
17.20%
11.23
209.46%
139.31
1,140.73%
126.96
8.86%
working capital
108.18M
-
74.97M
30.70%
70.52M
5.93%
67.97M
3.61%
111.34M
63.80%
225.97M
102.95%
262.41M
16.13%
880.68M
235.62%
12.50B
1,319.61%
11.03B
11.74%

All numbers in USD (except ratios and percentages)